GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inspire Medical Systems Inc (FRA:2DR) » Definitions » Change In Receivables

Inspire Medical Systems (FRA:2DR) Change In Receivables : €-11.8 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Inspire Medical Systems Change In Receivables?

Inspire Medical Systems's change in receivables for the quarter that ended in Mar. 2024 was €17.4 Mil. It means Inspire Medical Systems's Accounts Receivable declined by €17.4 Mil from Dec. 2023 to Mar. 2024 .

Inspire Medical Systems's change in receivables for the fiscal year that ended in Dec. 2023 was €-27.7 Mil. It means Inspire Medical Systems's Accounts Receivable increased by €27.7 Mil from Dec. 2022 to Dec. 2023 .

Inspire Medical Systems's Accounts Receivable for the quarter that ended in Mar. 2024 was €66.5 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Inspire Medical Systems's Days Sales Outstanding for the three months ended in Mar. 2024 was 40.24.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Inspire Medical Systems's liquidation value for the three months ended in Mar. 2024 was €389.4 Mil.


Inspire Medical Systems Change In Receivables Historical Data

The historical data trend for Inspire Medical Systems's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inspire Medical Systems Change In Receivables Chart

Inspire Medical Systems Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only -5.83 -9.73 -8.18 -25.50 -27.71

Inspire Medical Systems Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.39 -4.25 -7.94 -17.08 17.45

Inspire Medical Systems Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-11.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Inspire Medical Systems  (FRA:2DR) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Inspire Medical Systems's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=66.546/150.889*91
=40.24

2. In Ben Graham's calculation of liquidation value, Inspire Medical Systems's accounts receivable are only considered to be worth 75% of book value:

Inspire Medical Systems's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=406.052-89.073+0.75 * 66.546+0.5 * 45.056
=389.4

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Inspire Medical Systems Change In Receivables Related Terms

Thank you for viewing the detailed overview of Inspire Medical Systems's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Inspire Medical Systems (FRA:2DR) Business Description

Traded in Other Exchanges
Address
5500 Wayzata Boulevard, Suite 1600, Golden Valley, MN, USA, 55416
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Inspire Medical Systems (FRA:2DR) Headlines

No Headlines